JPH0368665B2 - - Google Patents
Info
- Publication number
- JPH0368665B2 JPH0368665B2 JP58157510A JP15751083A JPH0368665B2 JP H0368665 B2 JPH0368665 B2 JP H0368665B2 JP 58157510 A JP58157510 A JP 58157510A JP 15751083 A JP15751083 A JP 15751083A JP H0368665 B2 JPH0368665 B2 JP H0368665B2
- Authority
- JP
- Japan
- Prior art keywords
- arginine
- amino acids
- protein
- present
- bcaa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 claims description 20
- 229940024606 amino acid Drugs 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 12
- 239000004475 Arginine Substances 0.000 claims description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- 229960000310 isoleucine Drugs 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
- 239000004474 valine Substances 0.000 claims description 5
- 210000003205 muscle Anatomy 0.000 description 16
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 13
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 13
- 235000009697 arginine Nutrition 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 229960003136 leucine Drugs 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 229960004295 valine Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000007659 motor function Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000006742 locomotor activity Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 240000004668 Valerianella locusta Species 0.000 description 1
- 235000003560 Valerianella locusta Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- -1 aromatic amino acids Chemical class 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
本発明は、食品組成物に関し、特にスポーツや
肉体労働等の筋肉運動の機能を増強させるために
有用な食品組成物を提供することを目的とするも
のである。
イソロイシン、ロイシン、バリンの3種のアミ
ノ酸は、いずれも分岐鎖をもつ構造の類似性から
分岐鎖アミノ酸(以下BCAAと略称する)と呼
ばれ、生体内での代謝に、特徴的な共通点を持つ
ことが従来より知られている。すなわち、
BCAAは、他のアミノ酸が主として肝臓で代謝
されるのと異なり、筋肉で代謝される。肝疾患の
患者の血中では、芳香族アミノ酸の濃度が増し、
BCAAの濃度が低下するというアンバランスの
状態が起る。これに対してBCAAを投与すると
症状が改善されるので、BCAAは肝不全用栄養
組成物、特に輪液用組成物として利用されてきた
(例特開昭56−68374)。このような既存組成物は
一般に病人用のものであつて健康人を対象とする
ものではない。
一般に運動競技の選手においては筋力の最大限
の発揮が求められる反面、運動機能、運動技術の
駆使のため、あるいは、運動競技の目的以外のエ
ネルギーの浪費をさけるため、過大な体重増加は
好ましくないとされている。特にこの点で厳しい
条件にさらされるのは、柔道、レスリング、ウエ
イトリフテイング、ボクシング等体重制限の課せ
られる種目分野の競技選手であつて、激しい運動
をするのにもかかわらず、体重を制限枠内におさ
めるため節食ないし絶食を行うことも稀ではな
い。この際、栄養上の配慮が不適切であると、所
期の目的を達成し得ないのみならず、かえつて健
康を損う場合も生じ得るものである。
以上は典型的な例として、運動競技選手に焦点
を絞つて述べたが、一般市井人が、健康増進のた
めにスポーツを行うに当つても程度の差こそあ
れ、本質的には共通した問題に当面することも、
起り得ることである。
本発明は、このような条件下で、筋力の維持、
強化を計るために有用な食品組成物であつて、筋
の激しい使用に伴う代謝消耗に対し、必要なタン
パク質を充分に補いつつ、エネルギーについて比
較的少量の供給に止め、しかも筋に重点的にエネ
ルギーを供給し目的を果すものである。
本発明の大きい特徴は、目的食品組成物中のア
ミノ酸含量にある。すなわち、本発明者等は、イ
ソロイシン、ロイシン、バリンよりなるBCAA
の群から選ばれる1種または2種以上のアミノ酸
とアルギニンとを高濃度に含有し、高タンパク質
の食品組成物を摂取することによつて、筋肉運動
の機能を向上させることが可能であることを新に
見出し、本発明を完成させた。
本発明は以下に示す3つの特徴(a)(b)(c)即ち、(a)
イソロイシン、ロイシン、バリンよりなる群から
選ばれる1種又は2種以上のアミノ酸の含量の合
計が全アミノ酸の含量に対して30%以上である。
(b)アルギニンの含量が全アミノ酸の含量に対して
10%以上である。(c)タンパク質を30%以上含有す
る、を有する食品組成物である。これ等アミノ酸
は、特に、イソロイシン:ロイシン:バリン:ア
ルギンの割合が重量比で1.3〜0.6:1:0.4〜
0.8:1.4〜0.6となるように調製した時、特に効果
がすぐれている。この比率はこれ等アミノ酸の筋
肉中の平均的な存在比および筋肉における代謝速
度を調べて決めたものであり、アルギニンによる
インシユリンの分泌促進効果をもとに定めたもの
である。
更に、本発明においては、筋肉の主要構成成分
であるタンパク質の代謝消費される分を充分に補
い、加え、運動トレーニングの結果成長増大する
分に対応する必要をみたすに足りるよう、高濃度
に含有するように調製することが必要である。具
体的にはタンパク質の含量を30%以上とすること
が好ましい。使用原料としては、大豆タンパク
質、小麦グルテンなどの植物性タンパク質や、卵
粉、カゼインなどの動物性タンパク質など、どの
ようなものであつてもよい。これ等タンパク質を
酸あるいは酵素で処理し完全にあるいは部分的に
加水分解したものを用いることも本発明の範囲に
属するものである。
以上の他本発明による製品には、一般栄養成分
として、炭水化物類、油脂類、ミネラル類、ビタ
ミン類などを使用の態様に合わせて用いることが
出来る。
炭水化物類としては、米粉、小麦粉、小麦澱
粉、コーン・スターチ、甘藷澱粉、馬鈴薯澱粉な
ど澱粉や澱粉を主体とする原料素材、又はこれ等
の加工品、部分分解物、更に少糖類や単糖類を用
いる。
油脂類はエネルギー源としての他、必須脂肪酸
の給源として欠かし得ない。エネルギー供給を抑
制するために含量を低くする場合でも、少くとも
3%は含有するようにすべきである。大豆油、コ
ーン油、ナタネ油、綿実油、ヒマワリ油、パーム
油、オリーブ油などの植物油や、牛脂、豚脂、乳
脂、魚油などの動物油肥を用いることが出来、こ
れ等の油肥類をエステル交換や水素添加などによ
り加工したものであつてもよい。
ミネラル類としてはナトリウム、カリウム、カ
ルシウム、マグネシウム、鉄などの塩類が用いら
れる。
ビタミン類としては、脂溶性(A,D,E,
F,Kなど)および水溶性(B1,B2,B6,B12,
C,ナイアシン、など)の各ビタミンを用いるこ
とが出来る。
製品の嗜好性を向上させるため、調味料、香料
を適宜配合することが出来る。
製品の形態としては、溶液状、懸濁物状、粉末
状、練り物、成形物(錠、顆粒、棒、板)等の形
態を与えることが出来、これ等の形態に応じて乳
化剤、賦形剤を加えることも出来る。以上、本発
明の食品組成物の摂食形態は自由に選択出来、た
とえば水溶液とするなどの限定を要しない。
本発明の食品組成物を比較的少量たとえば1日
300g程度を摂取すれば、タンパク質の必要量を
充分に満たすことが出来る。含有するBCAA及
びアルギニンは速やかに吸収されて血中に移行し
体内各臓器に運ばれる。当然筋肉にも供給され利
用される。
BCAAは、他の一般のアミノ酸が主として肝
臓で代謝されるのとは異り、筋肉で代謝されて、
筋肉に対するエネルギーの給源となる。更にスト
レス下にある状態で生起し易い筋肉タンパク質の
分解を抑制し、合成を促すことが知られている。
アルギニンはいわゆる尿素サイクルの構成メンバ
ーの1員として、アミノ酸が代謝分解される時生
成するアンモニアを捕捉処理し尿素に転換する上
で重要な働きをしている。更に、アルギニンと
BCAAの内ロイシンとはそれぞれインシユリン
の分泌を刺戟し、筋肉に於ける代謝の流れを調節
することにも関与している。
以上の事実は本発明の目的が効果的に達せられ
ることを支持する理論的根拠である。要するに、
本発明により提供される食品組成物を摂取するこ
とにより筋肉運動の機能が維持増強される。
以下実施例により本発明をくわしく説明する。
実施例 1
表1に示す食品組成物を調製した。
表 1 食品組成物処方
L−イソロイシン 4.5%
L−ロイシン 4.0
L−バリン 2.0
L−アルギニン 4.0
卵白粉 58.0
コーンサラダ油 3.5
粉末クリーム 20.0
粉糖 10.0
インスタントコーヒー 2.0
この組成物は粉末状であつて、そのまま、ある
いは水乃至温湯に懸濁してスラーリーとし、水又
は温湯で混練して餅状とし、成形してステイツク
としていずれも好ましい風味を有し、摂食するこ
とが出来た。
この組成物はタンパク質50%を含有し、タンパ
ク質とアミノ酸の含量を合せると64.5%となる。
これに対するBCAAの総量の割合は34.3%、L−
アルギニンの割合は13.1%である。
実施例 2
雄、6週令(体重約170g、予備飼育して実験
環境にならしたもの)のSD系ラツトを各群10頭
ずつの3群に区分けし、各群の平均体重がほぼ同
レベルになるようにした。
ラツトは自由運動が可能な回転籠(円周1m)
を附設したケージに1ケージに1頭ずつ収容し
た。
ケージはすべて動物飼育室内におき、室温23±
1℃、湿度55±10%にそれぞれ保ち、照明は12時
間暗、12時間明という条件が定期的にくりかえさ
れるように設定した。飼料はペアード・フイード
法により与え、水は自由に飲ませた。
3群に与えた飼料の組成を表2に示す。
The present invention relates to a food composition, and an object of the present invention is to provide a food composition that is particularly useful for enhancing muscle exercise functions such as sports and manual labor. Three types of amino acids, isoleucine, leucine, and valine, are called branched-chain amino acids (hereinafter abbreviated as BCAA) because of the similarity in their structure with branched chains, and they have common characteristics in their metabolism in living organisms. It has been known for a long time to have. That is,
BCAAs are metabolized in the muscles, unlike other amino acids, which are primarily metabolized in the liver. In the blood of patients with liver disease, the concentration of aromatic amino acids increases;
An unbalanced state occurs in which the concentration of BCAAs decreases. On the other hand, since the symptoms are improved when BCAA is administered, BCAA has been used as a nutritional composition for liver failure, especially as a composition for annular fluid (eg, Japanese Patent Application Laid-Open No. 56-68374). Such existing compositions are generally intended for use by sick people and not for healthy people. In general, athletes in athletics are required to maximize their muscular strength, but excessive weight gain is not desirable in order to make full use of motor function and technique, or to avoid wasting energy for purposes other than the purpose of athletics. It is said that Athletes in sports such as judo, wrestling, weightlifting, and boxing that are subject to weight restrictions are particularly exposed to severe conditions in this regard, and despite engaging in strenuous exercise, athletes who do not exceed the weight limit limit are often exposed to severe conditions. It is not uncommon for people to refrain from eating or fasting in order to keep it under control. In this case, if nutritional considerations are inappropriate, not only will the intended purpose not be achieved, but health may even be harmed. The above has focused on athletes as a typical example, but when ordinary citizens participate in sports to improve their health, there are essentially common problems, albeit to varying degrees. For the time being,
It can happen. The present invention aims to maintain muscle strength and maintain muscle strength under such conditions.
A food composition useful for measuring muscle strength, which supplies a relatively small amount of energy while sufficiently supplementing the necessary protein to combat metabolic depletion that accompanies intense muscle use, and which focuses on muscle strength. It provides energy and serves a purpose. A major feature of the present invention lies in the amino acid content in the target food composition. That is, the present inventors discovered that BCAA consisting of isoleucine, leucine, and valine
It is possible to improve muscle motor function by ingesting a high protein food composition containing a high concentration of one or more amino acids selected from the group of arginine and arginine. They made a new discovery and completed the present invention. The present invention has the following three features (a), (b), and (c), namely, (a)
The total content of one or more amino acids selected from the group consisting of isoleucine, leucine, and valine is 30% or more of the total amino acid content.
(b) Arginine content relative to total amino acid content
10% or more. (c) A food composition containing 30% or more protein. In particular, these amino acids have a weight ratio of isoleucine:leucine:valine:algin of 1.3 to 0.6:1:0.4.
The effect is particularly excellent when the ratio is adjusted to 0.8:1.4 to 0.6. This ratio was determined by examining the average abundance ratio of these amino acids in muscle and the metabolic rate in muscle, and was determined based on the insulin secretion promoting effect of arginine. Furthermore, in the present invention, the protein is contained at a high concentration to sufficiently compensate for the metabolic consumption of protein, which is the main component of muscle, and also to meet the need for increased growth as a result of exercise training. It is necessary to prepare the Specifically, it is preferable that the protein content be 30% or more. The raw materials used may be of any kind, including vegetable proteins such as soybean protein and wheat gluten, and animal proteins such as egg powder and casein. It also falls within the scope of the present invention to use proteins that have been completely or partially hydrolyzed by treatment with acids or enzymes. In addition to the above, the product according to the present invention may contain carbohydrates, fats and oils, minerals, vitamins, etc. as general nutritional ingredients depending on the usage mode. Carbohydrates include starch and starch-based raw materials such as rice flour, wheat flour, wheat starch, corn starch, sweet potato starch, and potato starch, processed products and partially decomposed products of these, and oligosaccharides and monosaccharides. use Oils and fats are indispensable not only as an energy source but also as a source of essential fatty acids. Even if the content is lowered to suppress energy supply, it should be contained at least 3%. Vegetable oils such as soybean oil, corn oil, rapeseed oil, cottonseed oil, sunflower oil, palm oil, and olive oil, as well as animal oils and fertilizers such as beef tallow, lard, milk fat, and fish oil, can be used, and these oils and fertilizers can be transesterified. It may also be processed by hydrogenation or the like. As minerals, salts such as sodium, potassium, calcium, magnesium, and iron are used. As vitamins, fat-soluble (A, D, E,
F, K, etc.) and water-soluble (B 1 , B 2 , B 6 , B 12 ,
C, niacin, etc.) can be used. In order to improve the palatability of the product, seasonings and fragrances can be added as appropriate. The product can be in the form of a solution, suspension, powder, paste, molded product (tablet, granule, rod, plate), etc. Emulsifiers and excipients can be added depending on these forms. Agents can also be added. As mentioned above, the feeding form of the food composition of the present invention can be freely selected, and there is no need to limit it to, for example, an aqueous solution. The food composition of the present invention may be administered in relatively small amounts, for example, per day.
Ingesting around 300g is enough to meet your protein needs. The BCAA and arginine it contains are quickly absorbed and transferred into the blood, where they are transported to various organs in the body. Naturally, it is also supplied to and used by the muscles. Unlike other general amino acids, which are mainly metabolized in the liver, BCAA is metabolized in the muscles.
It is a source of energy for muscles. Furthermore, it is known to suppress the breakdown of muscle proteins, which tends to occur under stress, and promote synthesis.
As a member of the so-called urea cycle, arginine plays an important role in capturing ammonia produced when amino acids are metabolically decomposed and converting it into urea. Furthermore, arginine and
Leucine, a BCAA, stimulates the secretion of insulin and is also involved in regulating the flow of metabolism in muscles. The above facts are the rationale supporting that the purpose of the present invention can be effectively achieved. in short,
Muscle motor function is maintained and enhanced by ingesting the food composition provided by the present invention. The present invention will be explained in detail with reference to Examples below. Example 1 A food composition shown in Table 1 was prepared. Table 1 Food composition formulation L-isoleucine 4.5% L-leucine 4.0 L-valine 2.0 L-arginine 4.0 Egg white powder 58.0 Corn salad oil 3.5 Powdered cream 20.0 Powdered sugar 10.0 Instant coffee 2.0 This composition is in powder form and can be used as it is. Alternatively, it could be suspended in water or hot water to make a slurry, kneaded with water or hot water to form a rice cake, and molded into a stick, which had a desirable flavor and could be eaten. This composition contains 50% protein, with a combined protein and amino acid content of 64.5%.
The ratio of the total amount of BCAA to this is 34.3%, L-
The percentage of arginine is 13.1%. Example 2 Male SD rats, 6 weeks old (approximately 170 g in weight, preliminarily raised and accustomed to the experimental environment), were divided into 3 groups of 10 rats each, and the average weight of each group was approximately the same. I made it so that The rat is placed in a rotating cage (circumference: 1m) that allows free movement.
One animal per cage was housed in a cage with an attached cage. All cages were placed in an animal breeding room at a room temperature of 23±
The conditions were maintained at 1°C and humidity at 55±10%, and the lighting was set to be 12 hours dark and 12 hours bright, which were alternated periodically. Feed was provided using the paired feed method, and water was provided ad libitum. Table 2 shows the composition of the feed given to the three groups.
【表】
* ハーパーの組成によつた
表2の各供試飼料中のBCAA及びアルギニン
の含量を合計した値を表3に示す[Table] *Table 3 shows the total content of BCAA and arginine in each test feed in Table 2 according to Harper's composition.
【表】
実験供試飼料の給与開始、5日間を経てから毎
日、ラツトが回転籠を回した数を計測し、これを
もとに各ラツトの自発運動量を1日当り走行距離
(m)として算出した。測定は10日間継続した。
1日の自発走行距離を、BCAA、アルギニン
無添加区を1とした時の相対値で表5に示す。[Table] After 5 days from the start of feeding the experimental feed, the number of times the rats turned the rotating cage was measured every day, and based on this, the spontaneous locomotor activity of each rat was calculated as the distance traveled per day (m). did. Measurements continued for 10 days. Table 5 shows the daily spontaneous mileage as a relative value when the BCAA and arginine-free group is set as 1.
【表】【table】
【表】【table】
【表】
本発明の方法に従つて調製した飼料を摂取した
群は、最も高い自発走行量を示した。又、タンパ
ク質含量、BCAA含量及びアルギニン含量の低
い飼料を与えられた対照群では、もつとも自発運
動量が少かつた。[Table] The group that consumed the feed prepared according to the method of the present invention showed the highest amount of spontaneous running. In addition, the control group fed a diet with low protein, BCAA, and arginine content had significantly lower locomotor activity.
Claims (1)
品組成物 (a) イソロイシン、ロイシン、バリンよりなる群
から選ばれる1種又は2種以上のアミノ酸の含
量の合計が全アミノ酸の含量に対して30%以上
である。 (b) アルギニンの含量が、全アミノ酸の含量に対
して10%以上である。 (c) タンパク質を30%以上含有する。[Scope of Claims] 1. A food composition having the following three characteristics (a), (b), and (c): (a) one or more selected from the group consisting of isoleucine, leucine, and valine; The total content of amino acids is 30% or more of the content of all amino acids. (b) The content of arginine is 10% or more of the content of all amino acids. (c) Contains 30% or more protein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58157510A JPS6049764A (en) | 1983-08-29 | 1983-08-29 | Food composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58157510A JPS6049764A (en) | 1983-08-29 | 1983-08-29 | Food composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6049764A JPS6049764A (en) | 1985-03-19 |
JPH0368665B2 true JPH0368665B2 (en) | 1991-10-29 |
Family
ID=15651250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58157510A Granted JPS6049764A (en) | 1983-08-29 | 1983-08-29 | Food composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6049764A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009104696A1 (en) | 2008-02-19 | 2009-08-27 | 株式会社アーネストメディスン | Oral or enteral composition useful for recovery of physical functions |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2164632A1 (en) * | 1993-06-11 | 1994-12-22 | John P. Cooke | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
US5891459A (en) | 1993-06-11 | 1999-04-06 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
US7288570B2 (en) * | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
JPWO2005104873A1 (en) * | 2004-04-28 | 2008-03-13 | 大塚製薬株式会社 | Amino acid-containing food |
JP5545424B2 (en) * | 2005-03-29 | 2014-07-09 | 味の素株式会社 | Amino acid-containing composition for preventing or improving decrease in skeletal muscle mass in the elderly |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5467055A (en) * | 1977-10-17 | 1979-05-30 | Roussel Uclaf | Novel or known food having cellular structure and production |
JPS5711910A (en) * | 1980-06-25 | 1982-01-21 | Otsuka Shokuhin Kogyo Kk | Intestinal preparation of nutrition supplement |
JPS58126767A (en) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | Elemental diet for hepatopathic patient |
JPS58216122A (en) * | 1982-06-10 | 1983-12-15 | Meiji Milk Prod Co Ltd | Nutrient product for infant of histidinemia |
-
1983
- 1983-08-29 JP JP58157510A patent/JPS6049764A/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5467055A (en) * | 1977-10-17 | 1979-05-30 | Roussel Uclaf | Novel or known food having cellular structure and production |
JPS5711910A (en) * | 1980-06-25 | 1982-01-21 | Otsuka Shokuhin Kogyo Kk | Intestinal preparation of nutrition supplement |
JPS58126767A (en) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | Elemental diet for hepatopathic patient |
JPS58216122A (en) * | 1982-06-10 | 1983-12-15 | Meiji Milk Prod Co Ltd | Nutrient product for infant of histidinemia |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009104696A1 (en) | 2008-02-19 | 2009-08-27 | 株式会社アーネストメディスン | Oral or enteral composition useful for recovery of physical functions |
Also Published As
Publication number | Publication date |
---|---|
JPS6049764A (en) | 1985-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2294117C2 (en) | Shaped fish semi-finished product for preschool and school infant nutrition | |
CN101657106B (en) | Compositions and methods for controlling the weight of animals | |
RU2727661C1 (en) | Fodder compositions for domestic animals and related methods | |
CA2772996A1 (en) | Composition with high-protein content for the food industry | |
US20110251153A1 (en) | Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria | |
US20040156882A1 (en) | Method and composition for feeding mammals | |
CA2441192C (en) | The use of lysine for the prevention or treatment of stress-induced diseases | |
JP6538043B2 (en) | Methods and compositions for improving renal function | |
JP2002020312A (en) | Food composition for promoting reduction in body fat and promoter for reduction in body fat | |
KR20010084126A (en) | Manufacturing method for noodles | |
JPH0368665B2 (en) | ||
CN109480109A (en) | A kind of composition and preparation method thereof substituting plasma protein powder | |
CN103082148A (en) | Beef cattle feed | |
Zralý et al. | Effect of feeding amaranth on growth efficiency and health of market pigs | |
JPH09124473A (en) | Enhancer for physical fitness | |
Nicol et al. | The utilization of proteins and amino acids in diets based on cassava (Manihot utilissima), rice or sorghum (Sorghum sativa) by young Nigerian men of low income | |
WO2017038991A1 (en) | Composition for muscle building and method for building muscle | |
JPH0458304B2 (en) | ||
JP2644500B2 (en) | Animal protein-containing food composition and method of supplying the same | |
JP2019099498A (en) | Composition for promoting lipid metabolism | |
JP3895133B2 (en) | Meat quality improvement method for cultured fish | |
JP6778342B1 (en) | Pet food | |
JP7493934B2 (en) | Pet food | |
CN107439640A (en) | A kind of red barnyard grass piecrust and its manufacture craft | |
JP6272536B1 (en) | Feed additives for old livestock and feed for old livestock |